SPRC SciSparc Ltd.
$5.08▲ +2.63%
Healthcare
Other
After hours
$5.08▲ +0.00%
Sep 11, 7:30 PM ET
Volume 11.6K
Avg Volume (10D) 40.5K
Key Metrics & Fundamentals
Market Cap
$2.95M
P/E Ratio
0.1
Div Yield
–%
52W Range
2.98 - 80.10
% vs 50 MA
-14.71%
% vs 200 MA
-33.29%
RSI-14
36.9
MACD Histogram
-0.1700
Beta (1Y vs SPY)
-0.15
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation for Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
NewMediaWire · Sep 2, 2026 1:16 PM
NeuroThera Labs Achieves Significant Enrollment Momentum in SCI210 Autism Clinical Trial
NewMediaWire · Aug 31, 2026 8:05 PM
SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial
GlobeNewswire · Aug 31, 2026 8:03 PM
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · Aug 31, 2026 2:12 PM
SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board
GlobeNewswire · Aug 26, 2026 12:32 PM
SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
GlobeNewswire · Aug 24, 2026 12:51 PM
SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million
GlobeNewswire · Aug 18, 2026 12:06 PM
NeuroThera Labs Inc. Closes First Tranche of Non-Brokered Private Placement
NewMediaWire · Aug 12, 2026 9:01 PM
NeuroThera Labs Granted Japanese Patent for Its Proprietary, Innovative Therapeutic Combination
NewMediaWire · Aug 12, 2026 1:00 PM
SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination
GlobeNewswire · Aug 12, 2026 12:25 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Avg +0.90 · 2 posts
DiscussionTradeWith a little more volume this thing could absolutely rip
r/wallstreetbets · Jul 30, 2026
The post expresses strong enthusiasm for SPRC and encourages others to invest.
very_positive
+1.00
DiscussionTradeMemeTomorrow morning: $OPTT and $SPRC 🚀 (follow for more guesses)
r/wallstreetbets · Jan 6, 2025
The post uses '🚀' (rocket) indicating excitement and bullish sentiment.
very_positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.